User:Olivier Laprevote/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 23: Line 23:
The Vav1 <scene name='75/751211/Structure_vav/3'>structural domains</scene> are (from N ter to C ter): a '''calponin-homology''' (CH) domain, an '''acidic''' (Ac) domain, a '''DBL-homology''' (DH) domain also known as a '''rhoGEF''' domain, a '''pleckstrin-homology''' (PH) domain, a '''phorbol esters/diacylglycerol binding''' (C1) domain also called Zinc-finger domain and '''Src-homology''' (SH) 3 and 2 domains. <ref>http://smart.embl.de/smart/show_motifs.pl?GENOMIC=1&DO_PFAM=DO_PFAM&INCLUDE_SIGNALP=INCLUDE_SIGNALP&ID=9606.ENSP00000472929</ref> <ref>PMID:20141838 </ref>
The Vav1 <scene name='75/751211/Structure_vav/3'>structural domains</scene> are (from N ter to C ter): a '''calponin-homology''' (CH) domain, an '''acidic''' (Ac) domain, a '''DBL-homology''' (DH) domain also known as a '''rhoGEF''' domain, a '''pleckstrin-homology''' (PH) domain, a '''phorbol esters/diacylglycerol binding''' (C1) domain also called Zinc-finger domain and '''Src-homology''' (SH) 3 and 2 domains. <ref>http://smart.embl.de/smart/show_motifs.pl?GENOMIC=1&DO_PFAM=DO_PFAM&INCLUDE_SIGNALP=INCLUDE_SIGNALP&ID=9606.ENSP00000472929</ref> <ref>PMID:20141838 </ref>
-
<scene name='75/751211/Ch_domain/1'>Calponin-homology (CH) domain</scene> (residues 1 - 119): When the CH domain is deleted, Vav has a phosphorylation-independant GEF activity. Studies on Vav3 implies that CH plays a role in '''auto-inhibition''' of Vav via its interactions with the <scene name='75/751211/Ch_and_ac/1'>Ac</scene> (between the residue 49 in CH and 181 in Ac), DH and <scene name='75/751211/Ch_and_c1/1'>C1</scene> regions (C1 interacts with L101 and L104 of CH). The contacts with DH and C1 seem '''passively driven''' by the interactions between Ac and CH, though. <ref>PMID:15775967</ref>
+
<scene name='75/751211/Ch_domain/1'>Calponin-homology (CH) domain</scene> (residues 1 - 119): When the CH domain is deleted, Vav has a partial phosphorylation-independant GEF activity. <ref>PMID:15775967</ref>
<scene name='75/751211/Ac_domain/1'>Acidic (Ac) domain</scene> (residues 134 - 187): contains the Tyrosine (Y174) which '''activates Vav''' when phosphorylated. <ref>PMID:20141838 </ref>
<scene name='75/751211/Ac_domain/1'>Acidic (Ac) domain</scene> (residues 134 - 187): contains the Tyrosine (Y174) which '''activates Vav''' when phosphorylated. <ref>PMID:20141838 </ref>
Line 33: Line 33:
<scene name='75/751211/C1_domain/1'>Phorbol esters/diacylglycerol binding (C1) domain</scene> (508 - 584) : has a cooperative action with the DH domain to '''bind to the rho GTPase''' and to '''promote the GEF activity''' of Vav.
<scene name='75/751211/C1_domain/1'>Phorbol esters/diacylglycerol binding (C1) domain</scene> (508 - 584) : has a cooperative action with the DH domain to '''bind to the rho GTPase''' and to '''promote the GEF activity''' of Vav.
-
Src-homology domain 3:
+
Src-homology domains SH3-SH2-SH3 (residues 617 - 842): the activators of Vav like Syk or ZP-70 fix on its SH2 region <ref>PMID: 9850860</ref>. Potential inhibitors of Vav also dock on its SH3-SH2-SH3 region, such as SHP which would remove the phosphate on Y174 <ref>PMID: 8632004</ref> or Cbl-b <ref>PMID: 9399639</ref>. It has also been proven that the C-ter SH3 was involved in the auto-inhibition of Vav. <ref>PMID: 24736456  </ref>
 +
 
 +
== Auto-inhibition and activation ==
== Vav activity ==
== Vav activity ==

Revision as of 19:20, 27 January 2017

Proto-oncogene vav

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. http://mcb.asm.org/content/20/5/1461.full
  4. http://www.proteinatlas.org/ENSG00000141968-VAV1/tissue
  5. Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med. 2003 Nov 17;198(10):1595-608. PMID:14623913 doi:http://dx.doi.org/10.1084/jem.20030874
  6. Quaranta MG, Mattioli B, Spadaro F, Straface E, Giordani L, Ramoni C, Malorni W, Viora M. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 2003 Nov;17(14):2025-36. PMID:14597672 doi:http://dx.doi.org/10.1096/fj.03-0272com
  7. http://smart.embl.de/smart/show_motifs.pl?GENOMIC=1&DO_PFAM=DO_PFAM&INCLUDE_SIGNALP=INCLUDE_SIGNALP&ID=9606.ENSP00000472929
  8. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  9. Llorca O, Arias-Palomo E, Zugaza JL, Bustelo XR. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. EMBO J. 2005 Apr 6;24(7):1330-40. Epub 2005 Mar 10. PMID:15775967 doi:http://dx.doi.org/10.1038/sj.emboj.7600617
  10. Yu B, Martins IR, Li P, Amarasinghe GK, Umetani J, Fernandez-Zapico ME, Billadeau DD, Machius M, Tomchick DR, Rosen MK. Structural and energetic mechanisms of cooperative autoinhibition and activation of Vav1. Cell. 2010 Jan 22;140(2):246-56. PMID:20141838 doi:10.1016/j.cell.2009.12.033
  11. http://pfam.xfam.org/family/PF00621
  12. Movilla N, Bustelo XR. Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol. 1999 Nov;19(11):7870-85. PMID:10523675
  13. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM, Falck JR, White MA, Broek D. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science. 1998 Jan 23;279(5350):558-60. PMID:9438848
  14. Chu DH, Morita CT, Weiss A. The Syk family of protein tyrosine kinases in T-cell activation and development. Immunol Rev. 1998 Oct;165:167-80. PMID:9850860
  15. Kon-Kozlowski M, Pani G, Pawson T, Siminovitch KA. The tyrosine phosphatase PTP1C associates with Vav, Grb2, and mSos1 in hematopoietic cells. J Biol Chem. 1996 Feb 16;271(7):3856-62. PMID:8632004
  16. Bustelo XR, Crespo P, Lopez-Barahona M, Gutkind JS, Barbacid M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene. 1997 Nov 20;15(21):2511-20. PMID:9399639
  17. PMID: 24736456 

Proteopedia Page Contributors and Editors (what is this?)

Olivier Laprevote

Personal tools